U.S. FDA Clears IND for First-in-Class Anti-B7H7 Antibody, Announces Harbour BioMed

Harbour BioMed, HKEX 02142 (the “Company”) announced that the U.S. Food and Drug Administration has approved the application for an investigational new drug to begin clinical trials in the U.S. of its first-in class fully human monoclonal antibodies HBM1020 against B7H7. This multicenter, open-label study will evaluate HBM1020’s safety, tolerability and pharmacokinetics as well as its […]

Scientists Validate Effective Rehabilitation and Recovery of Human Donor Lungs Previously Considered Unsuitable for Transplantation

The study shows that a new technique for regenerating donor lung tissue can increase the number organs available for lifesaving transplantation. According to a study recently published in the Journal of Heart and Lung Transplantation, a novel method of supporting and recovering donor lung outside the body has the potential to increase organs available for donation. […]

Innovative Gene Therapy Shows Promise in Treating Specific Types of Bladder Cancers

FDA recently approved the first gene therapy to treat high-risk bladder tumors that have not spread to muscle. In a news release, the agency described nadofaragene Firadenovec-vncg as a nonreplicating vector-based genetherapy for adults with non-muscle-invasive urethral cancer (NMIBC), who do not respond to immunotherapy using bacillus Calmette-Guerin. According to the FDA, about 75% to 80% […]

New vaccine shows potential in combating and preventing brain cancer

Scientists have discovered a way to transform cancer cells into powerful anticancer agents. Researchers have developed an innovative cell therapy to eradicate tumors and instill long-term immunity. This will train the immune system and prevent it from returning. The team’s early research showed promising results when they tested their dual-action cancer-killing vaccination in a mouse […]

Pill-based Drug Delivery Method Shows Promise as a Substitute for Injections

Injections are often required for lifelong treatment of chronic diseases such as rheumatoid arthritis. Patients skip doses due to fear of needles, infection from injections and pain. This encourages the development new delivery strategies which combine efficacy and minimal side effects. Researchers from Baylor College of Medicine, along with other institutions that collaborated on the project, […]